The civic record
Read. Follow. Verify.Idaho House Bill 648 Requires Equal Cost Sharing for Oral and Injected Anticancer Medications
Last action · April 1, 2026: Reported Signed by Governor on March 31, 2026 Session Law Chapter 259 Effective: 07/01/2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Idaho health benefit plans issued or renewed on or after January 1, 2027, must ensure that prescribed oral anticancer medications have cost-sharing requirements no less favorable than those applied to injected or intravenously administered anticancer medications.
Changes insurance coverage rules for patients taking cancer drugs by prohibiting health plans from charging higher copayments, , or deductibles for oral medications compared to intravenous or injected alternatives.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Health benefit plan enrollees
Enrollees prescribed oral anticancer medications will have cost sharing equalized with injected or intravenous treatments starting January 1, 2027.
Health insurance issuers
Health plans must adjust their cost-sharing structures, copayments, coinsurance, and deductibles for oral anticancer drugs to match intravenous and injected treatments.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
When do these new insurance rules take effect for health plans?
Can health insurance plans still require prior authorization for cancer medications?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
23 actions- Apr 1, 2026EnrolledReported Signed by Governor on March 31, 2026 Session Law Chapter 259 Effective: 07/01/2026
- Mar 27, 2026Delivered to Governor at 12:01 p.m. on March 27, 2026
- Mar 27, 2026Returned Signed by the President; Ordered Transmitted to Governor
- Mar 26, 2026Signed by President; returned to House
- Mar 26, 2026Received from the House enrolled/signed by Speaker
- Mar 26, 2026Reported Enrolled; Signed by Speaker; Transmitted to Senate
Show 17 earlier actions
- Mar 25, 2026FloorReturned from Senate Passed; to JRA for Enrolling
- Mar 25, 2026FloorRead third time in full – PASSED - 31-3-1 AYES – Adams, Bernt, Bjerke(Bjerke), Blaylock, Burtenshaw, Carlson, Cook, Den Hartog, Foreman, Galloway, Grow, Guthrie, Harris, Hart, Keyser, Lakey, Lenney, Lent, Nichols, Okuniewicz, Rabe, Ricks, Ruchti, Semmelroth, Taylor, Toews, Ward-Engelking, Wintrow, Woodward, Zito, Zuiderveld NAYS – Anthon, Kohl, Shippy Absent and excused – VanOrden Floor Sponsor - Blaylock Title apvd - to House
- Mar 20, 2026Read second time; filed for Third Reading
- Mar 19, 2026Reported out of Committee with Do Pass Recommendation; Filed for second reading
- Mar 11, 2026IntroducedIntroduced, read first time; referred to: Commerce & Human Resources
- Mar 11, 2026FloorReceived from the House passed; filed for first reading
- Mar 10, 2026FloorRead Third Time in Full – PASSED - 66-4-0 AYES – Alfieri, Barbieri, Beiswenger, Berch, Bingham, Boyle, Bruce, Burgoyne, Cannon, Cheatum, Church, Cornilles, Crane(12), Crane(13), Dygert, Egbert, Ehardt, Ehlers, Erickson(Larsen), Fuhriman, Furniss, Galaviz, Gannon, Garner, Green, Hall(Stone), Handy, Harris, Haws, Healey, Hill, Holtzclaw, Hostetler, Leavitt, Manwaring, Mathias, McCann, Mendive, Mickelsen, Miller, Mitchell, Monks, Nelsen, Palmer, Petzke, Pickett, Pohanka, Price, Rasor, Raybould, Raymond, Redman, Rubel, Sauter, Scott, Shepherd, Shirts, Skaug, Tanner(13), Tanner(14), Thompson, Vander Woude, Veile, Weber, Wheeler, Mr. Speaker NAYS – Cayler, Hawkins, Marmon, Wisniewski Absent – None Floor Sponsors - Bruce & Green Title apvd - to Senate
- Mar 9, 2026U.C. to hold place on third reading calendar one legislative day
- Mar 6, 2026U.C. to hold place on third reading calendar until Monday, March 9, 2026
- Mar 5, 2026U.C. to hold place on third reading calendar one legislative day
- Mar 4, 2026U.C. to hold place on third reading calendar one legislative day
- Mar 3, 2026Read second time; Filed for Third Reading
- Mar 2, 2026Reported out of Committee with Do Pass Recommendation, Filed for Second Reading
- Feb 17, 2026CommitteeReferred to Business
- Feb 17, 2026Reported out of Committee, Returned to the Desk for re-referral
- Feb 13, 2026CommitteeReported Printed and Referred to Health & Welfare
- Feb 12, 2026IntroducedIntroduced, read first time, referred to JRA for Printing
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Connected Entities
Sources
legislature.idaho.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools